Your browser doesn't support javascript.
Novel phenotypes of coronavirus disease: a temperature-based trajectory model.
Shen, Yanfei; Chen, Dechang; Huang, Xinmei; Cai, Guolong; Xu, Qianghong; Hu, Caibao; Yan, Jing; Liu, Jiao.
  • Shen Y; Department of Intensive Care, Zhejiang Hospital, Hangzhou, Zhejiang, China.
  • Chen D; Department of Intensive Care, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huang X; Department of Internal Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Cai G; Department of Intensive Care, Zhejiang Hospital, Hangzhou, Zhejiang, China.
  • Xu Q; Department of Intensive Care, Zhejiang Hospital, Hangzhou, Zhejiang, China.
  • Hu C; Department of Intensive Care, Zhejiang Hospital, Hangzhou, Zhejiang, China.
  • Yan J; Department of Intensive Care, Zhejiang Hospital, Hangzhou, Zhejiang, China. zjicu@vip.163.com.
  • Liu J; Department of Internal Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. catherine015@163.com.
Ann Intensive Care ; 11(1): 121, 2021 Aug 03.
Article in English | MEDLINE | ID: covidwho-1338128
ABSTRACT

BACKGROUND:

Coronavirus disease has heterogeneous clinical features; however, the reasons for the heterogeneity are poorly understood. This study aimed to identify clinical phenotypes according to patients' temperature trajectory.

METHOD:

A retrospective review was conducted in five tertiary hospitals in Hubei Province from November 2019 to March 2020. We explored potential temperature-based trajectory phenotypes and assessed patients' clinical outcomes, inflammatory response, and response to immunotherapy according to phenotypes.

RESULTS:

A total of 1580 patients were included. Four temperature-based trajectory phenotypes were identified normothermic (Phenotype 1); fever, rapid defervescence (Phenotype 2); gradual fever onset (Phenotype 3); and fever, slow defervescence (Phenotype 4). Compared with Phenotypes 1 and 2, Phenotypes 3 and 4 had a significantly higher C-reactive protein level and neutrophil count and a significantly lower lymphocyte count. After adjusting for confounders, Phenotypes 3 and 4 had higher in-hospital mortality (adjusted odds ratio and 95% confidence interval 2.1, 1.1-4.0; and 3.3, 1.4-8.2, respectively), while Phenotype 2 had similar mortality, compared with Phenotype 1. Corticosteroid use was associated with significantly higher in-hospital mortality in Phenotypes 1 and 2, but not in Phenotypes 3 or 4 (p for interaction < 0.01). A similar trend was observed for gamma-globulin.

CONCLUSIONS:

Patients with different temperature-trajectory phenotypes had different inflammatory responses, clinical outcomes, and responses to corticosteroid therapy.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Ann Intensive Care Year: 2021 Document Type: Article Affiliation country: S13613-021-00907-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Ann Intensive Care Year: 2021 Document Type: Article Affiliation country: S13613-021-00907-4